Algert Global LLC increased its stake in LifeVantage Corp (NASDAQ:LFVN) by 54.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 113,170 shares of the company’s stock after acquiring an additional 40,001 shares during the period. Algert Global LLC owned approximately 0.80% of LifeVantage worth $1,244,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in LFVN. Renaissance Technologies LLC grew its position in LifeVantage by 36.1% in the third quarter. Renaissance Technologies LLC now owns 1,011,805 shares of the company’s stock worth $11,120,000 after acquiring an additional 268,354 shares in the last quarter. Acadian Asset Management LLC grew its position in LifeVantage by 190.9% in the third quarter. Acadian Asset Management LLC now owns 291,624 shares of the company’s stock worth $3,204,000 after acquiring an additional 191,382 shares in the last quarter. BlackRock Inc. grew its position in LifeVantage by 210.9% in the third quarter. BlackRock Inc. now owns 238,160 shares of the company’s stock worth $2,618,000 after acquiring an additional 161,555 shares in the last quarter. Dimensional Fund Advisors LP grew its position in LifeVantage by 76.5% in the third quarter. Dimensional Fund Advisors LP now owns 258,262 shares of the company’s stock worth $2,838,000 after acquiring an additional 111,974 shares in the last quarter. Finally, Manatuck Hill Partners LLC purchased a new position in LifeVantage in the second quarter worth about $475,000. Institutional investors own 29.03% of the company’s stock.
Shares of NASDAQ LFVN opened at $14.07 on Friday. The company has a quick ratio of 1.16, a current ratio of 1.72 and a debt-to-equity ratio of 0.12. The stock has a market capitalization of $206.60 million, a price-to-earnings ratio of 27.65 and a beta of 0.97. LifeVantage Corp has a 1 year low of $3.20 and a 1 year high of $14.95.
LifeVantage (NASDAQ:LFVN) last announced its quarterly earnings data on Thursday, November 1st. The company reported $0.07 earnings per share (EPS) for the quarter. The business had revenue of $55.61 million during the quarter. LifeVantage had a net margin of 2.79% and a return on equity of 35.56%. On average, sell-side analysts predict that LifeVantage Corp will post 0.56 earnings per share for the current fiscal year.
TRADEMARK VIOLATION NOTICE: This report was posted by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this report on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The original version of this report can be viewed at https://www.thelincolnianonline.com/2018/12/08/algert-global-llc-buys-40001-shares-of-lifevantage-corp-lfvn.html.
LifeVantage Company Profile
LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and skin care products. The company offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; Axio, a line of energy drink mixes; Omega+, a fish oil dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3; and PhysIQ, a weight management system, as well as Petandim for Dogs, a companion pet supplement formulated to treat oxidative stress in dogs.
Read More: Diversification
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.